Childhood glucocorticoid use can lead to reduced adult height Clinical study 15 January 2013 Pages: 1 - 1
Corticosteroid use and MetS in systemic lupus erythematosis Epidemiology clinical study 15 January 2013 Pages: 2 - 2
Giving antibiotics to infants aged less than six months is linked to increased body mass in later childhood, Epidemiology clinical study 15 January 2013 Pages: 3 - 3
A meta-analysis has identified a significantly increased risk of serious adverse events and treatment discontinuation in patients receiving telaprevir Non-clinical study 15 January 2013 Pages: 3 - 3
Bristol-Myers Squibb (BMS) is voluntarily recalling certain batches of BiCNU [carmustine for injection] due to potential overfilling Media release 15 January 2013 Pages: 4 - 4
Labelling changes, new serious adverse reactions for levofloxacin News item 15 January 2013 Pages: 4 - 4
The Centre for Adverse Reactions Monitoring, New Zealand, has received 360 reports of liver injury associated with the use of non-tuberculosis antibiotics News item 15 January 2013 Pages: 4 - 4
The Indian Drug Technical Advisory Board (DTAB) has recommended that the strength of paracetamol in prescription combination products be limited News item 15 January 2013 Pages: 5 - 5
The Pharmacovigilance Programme of India has published a summary of reported ADRs for July to December 2011, News item 15 January 2013 Pages: 5 - 5
The Centers for Medicare and Medicaid Services has granted a temporary New Technology Add-on Payment for glucarpidase [Voraxaze], Media release 15 January 2013 Pages: 5 - 5
Auxilium Pharmaceuticals has announced a safety update following 30 months of post-approval use of Xiaflex Media release 15 January 2013 Pages: 5 - 5
The EMA has strengthened information sharing arrangements with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Media release 15 January 2013 Pages: 5 - 5
New Zealand's CARM* has received 53 reports of tendon disorders associated with the use of quinolone antibiotics since 2007. Incidence study 15 January 2013 Pages: 5 - 5
The New Zealand Medicines Adverse Reactions Committee (MARC) concluded that there is a small, but significant, association between statin use News item 15 January 2013 Pages: 5 - 5
Oral or intravenous haloperidol is unlikely to provide any further benefit at dosages exceeding 10 mg/day; News item 15 January 2013 Pages: 5 - 5